SCHEMBL18308783

SCHEMBL18308783

Cc1ccc(-c2cc(C)cc(-c3ccc(P)c(C)c3)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 2/20 0.37
▸ RXRB P28702 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ DHODH Q02127 1/20 0.35
▸ MCL1 Q07820 1/20 0.34
▸ ACHE P22303 1/20 0.32
▸ NPC1 O15118 3/20 0.32
▸ RAB9A P51151 3/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ AR P10275 1/20 0.32
▸ HSD17B1 P14061 1/20 0.32
▸ HSD17B2 P37059 1/20 0.32
▸ RAPGEF4 Q8WZA2 1/20 0.31
▸ CA1 P00915 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308768 0.92 TDP1 (0.41) TDP1ALDH1A1CYP3A4TSHRMCL1
SCHEMBL18308732 0.92 TDP1 (0.41) TDP1ALDH1A1CYP3A4TSHRMCL1
SCHEMBL18308801 0.88 HSD17B1 (0.43) TDP1ALDH1A1CYP3A4TSHRDHODH
SCHEMBL18308752 0.85 ALDH1A1 (0.46) TDP1ALDH1A1CYP3A4TSHRMCL1
SCHEMBL18308779 0.84 RXRA (0.33) RXRARXRBTDP1ALDH1A1CYP3A4
SCHEMBL18308738 0.82 ALDH1A1 (0.48) RXRBTDP1ALDH1A1CYP3A4TSHR
SCHEMBL18308769 0.82 ESR2 (0.38) TDP1ALDH1A1CYP3A4TSHRMCL1
SCHEMBL25951281 0.80 ACHE (0.50) RXRARXRBTDP1ALDH1A1DHODH
SCHEMBL18308730 0.79 ALDH1A1 (0.41) TDP1ALDH1A1CYP3A4TSHRHSD17B1
SCHEMBL18308799 0.79 RXRA (0.42) RXRARXRBTDP1DHODHMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-08 — — US disclosed
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS GMBH, MERCK PATENT (DE) 2017-05-04 — — US disclosed
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2016-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays VCL, ILK, LCP1 RXRA 2691/4885RXRB 3380/4885TDP1 3248/4885
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, LCP1, MAP1LC3C RXRA 1974/4885RXRB 2761/4885TDP1 3487/4885
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, PLEC, EML4 RXRA 2009/4885RXRB 2698/4885TDP1 2439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback